Attached files

file filename
8-K - 8-K - IDEX CORP /DE/d341712d8k.htm
EX-99.2 - EX-99.2 - IDEX CORP /DE/d341712dex992.htm
First Quarter 2012 Earnings Release
1
April 24, 2012
Exhibit 99.1


Agenda
2
Q1 2012 Summary
2012 Segment Performance
Fluid & Metering
Health & Science
Fire & Safety / Diversified
2012 Guidance Update
Q&A


Replay Information
Dial toll–free:
855.859.2056 
International:
404.537.3406
Conference ID:
#40915423
Log on to:
www.idexcorp.com
3


4
Cautionary Statement
Under the Private Securities
Litigation Reform Act
This
presentation
and
discussion
will
include
forward-looking
statements. 
Our
actual
performance
may
differ
materially
from
that
indicated
or
suggested
by
any
such
statements.
There
are
a
number
of
factors
that
could
cause
those
differences,
including
those
presented
in
our
most
recent
annual
report
and
other
company
filings
with
the
SEC.


IDEX Q1 Financial Performance
5


Fluid & Metering
6
6
Q1 Sales Mix:
Organic
+8%
Acquisition
-
Fx
-1%
Total                                                            
+7%
Q1 Summary:
Strong top line growth; North America and Emerging
markets
Energy, Chemical, Industrial & Agriculture very
strong
Industrial Water solid / Muni Wastewater stabilizing
Excellent operational execution
* Op Margin data adjusted for restructuring expense


Health & Science
7
7
Q1 Sales Mix:
Organic
+2%
Acquisition
+33%
Fx
-
Total                                                            
+35%
Q1 Summary:
Balanced view on end markets
New products and increased content supporting
growth
CVI integration on track
Completed PPC deal; M&A pipeline remains full
* Op Margin data adjusted for restructuring expense


Fire & Safety / Diversified
8
8
Q1 Sales Mix:
Organic
+7%
Acquisition
-
Fx
-2%
Total                                                            
+5%
Q1 Summary:
Strong top line growth; emerging & adjacent markets
Large dispensing replenishment order
Solid backlog, well positioned for remainder of  2012
Restructuring efforts and leverage driving profitability
* Op Margin data adjusted for restructuring expense


9
Q2 2012
EPS
estimate
range:
$0.70
-
$0.72
Mid-to-high single digit organic revenue growth
Negative Fx impact of ~2% to sales (at March 31 rates)
Positive impact of  ~6% from acquisitions
FY 2012
EPS
estimate
range:
$2.80
-
$2.85
Organic revenue growth in the mid-single digits
Operating margin of ~19%
Negative Fx impact of  ~2% to sales (at March 31 rates)
Positive impact of ~3% from acquisitions
Other modeling items
Tax rate ~ 30%
Cap Ex $40M
Free Cash Flow will exceed net income
EPS estimate excludes future restructuring, acquisitions and acquisition 
related costs and charges